News
9 October 2024
PsychoGenics Inc. has secured a contract from the National Institutes of Health (NIH) to explore and identify new investigational therapies for pain management.
Read more...8 October 2024
HoneyNaps announced on 9 September that it has commenced exports of its artificial intelligence sleep disorder diagnostic software, SOMNUM, to two medical institutions in the United States.
Read more...8 October 2024
Researchers announced significant findings from a pilot study conducted in partnership with Precision Neuroscience Corporation at the Society for Neuroscience (SfN) Neuroscience
Read more...7 October 2024
At the Neuroscience 2024 conference, Bruker Corporation (Nasdaq: BRKR) unveiled the OptoVolt? module, designed to enhance neuroscience research capabilities on the Ultima multiphoton microscope platform.
Read more...OrthAlign, a private medical device company, has secured FDA 510(k) clearance for its Lantern Hip handheld technology, specifically designed for direct anterior total hip arthroplasty
Read more...Qventus, a leader in AI-driven healthcare software, has announced that Ardent Health, a prominent healthcare provider across the U.S., has adopted Qventus? Perioperative Solution to enhance its robotics programme and boost surgical growth.
Read more...4 October 2024
HealthAxis, a leader in healthcare administration technology and business process operations, has announced a strategic partnership with COPE Health Solutions (CHS), a national expert in value-based care
Read more...3 October 2024
Trividia Health, Inc. has announced that its TRUE METRIX? Self-Monitoring Blood Glucose System will be the preferred choice for all Managed Medicaid Plans in Florida, including Fee-for-Service Medicaid, starting October 1st.
Read more...Soniquence?, LLC, a leader in radiofrequency (RF) technology for over 60 years, is thrilled to announce its new role as a global service and support provider for all Ellman? RF devices
Read more...2 October 2024
Conformal Medical, Inc. has launched the GLACE Study, a European clinical trial designed to evaluate the use of intracardiac echocardiography (ICE) imaging for left atrial appendage (LAA) closure in patients with non-valvular atrial fibrillation.
Read more...